Trisalus Life Sciences Inc (TLSI) - News Archive

In the ever-evolving landscape of medical technology, TriSalus Life Sciences continues to push the boundaries of cancer treatment. This innovative oncology company, known for its commitment to integrating novel delivery...

Transforming Oncology: TriSalus Life Sciences Unveils Innovations and Financial Progress Amid Upcoming Investor Engagements TriSalus Life Sciences Inc. (Nasdaq: TLSI), an emerging leader in oncology focused on redefinin...

In a significant development in the field of oncology, TriSalus Life Sciences, Inc. announced the publication of new research that highlights the effectiveness of its innovative drug delivery system in targeting solid t...

TriSalus Reports Q2 2024 Financial Results and Business Update In a recent announcement, TriSalus Life Sciences, a leader in the development of innovative therapies for solid tumors, shared its financial results for the...

TriSalus Life Sciences Announces Results of Exchange Offer and Consent Solicitation for WarrantsTriSalus Life Sciences Inc., an oncology company focused on improving treatment for patients with liver and pancreatic tumo...

Delivering Hope: TriSalus Life Sciences Innovative Approach in Combating Liver and Pancreatic Cancers In a landscape where advances in oncology are often measured in incremental steps, TriSalus Life Sciences, Inc. (Nasd...

TriSalus Life Sciences Initiates Exchange Offer and Consent Solicitation for Warrants DENVER - TriSalus Life Sciences Inc. (Nasdaq: TLSI), a prominent oncology company known for its innovative delivery technology integr...